Cellectar Biosciences, Inc. (CLRB) short interest & options flow
NASDAQCLRB short interest surges 706% in one month to 9.1% of float, while cost to borrow skyrockets to 323% — highest leverage in the biotech name's recent history.
- Market cap
- $12M
- Next earnings
- 10 Nov 2026
Key data as of 10 Nov 2026
Latest signals on CLRB
- Short Interest
CLRB short interest surges 706% in one month to 9.1% of float, while cost to borrow skyrockets to 323% — highest leverage in the biotech name's recent history.
- Utilization
CLRB utilization surges to 97.71%, nearing 52-week peak of 100%, as short interest explodes 1,379% in one day to 6.5% of float.
- Cost to Borrow
CLRB cost to borrow explodes to 150.4% — up 767% in one week as short interest surges 1,572% and utilization hits 98%.
CLRB news and analysis
RSSNo long-form analysis yet for CLRB. Pulse alerts and the live data picture are available on ORTEX.
Open CLRB on ORTEX →Want the live picture for CLRB?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CLRB — free to start on ORTEX.
Sign up for free →Open CLRB on ORTEX